Immuneering (IMRX) Accumulated Depreciation (2020 - 2022)

Immuneering's Accumulated Depreciation history runs 3 years deep, the most recent figure standing at $418337.0 for Q4 2022.

• On a quarterly basis, Accumulated Depreciation rose 140.12% year-over-year to $418337.0 in Q4 2022; TTM through Dec 2022 was $418337.0, a 140.12% increase from a year earlier, with the FY2022 full-year figure at $418337.0, up 140.12% from the prior year.
• Accumulated Depreciation advanced to $418337.0 in Q4 2022 per IMRX's latest filing, from $344556.0 in the prior quarter.
• Across five years, Accumulated Depreciation topped out at $418337.0 in Q4 2022 and bottomed at $128752.0 in Q4 2020.
• The 3-year median for Accumulated Depreciation is $198071.0 (2021), against an average of $233887.4.
• Across the five-year window, Accumulated Depreciation jumped 35.31% in 2021 and surged 140.12% in 2022, its largest moves.
• Year by year, Accumulated Depreciation stood at $128752.0 in 2020, then soared by 35.31% to $174219.0 in 2021, then jumped by 140.12% to $418337.0 in 2022.
• Per Business Quant, the three latest IMRX Accumulated Depreciation figures stand at $418337.0 (Q4 2022), $344556.0 (Q3 2022), and $276482.0 (Q2 2022).